Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,573 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07330466Recruiting
Does spinal cord stimulation work beyond a placebo?
This study investigates whether spinal cord stimulation (a device that sends mild electrical pulses to the spine to relieve pain) still works even when patients don't know if it's on. This helps separate the device's true effect from the expectation of feeling better.
Aarhus NAges 18 years+ - NCT07330596RecruitingPhase 2
Study of QL1706 plus chemo for lung cancer that got worse after immunotherapy
This trial tests a new drug called QL1706 combined with chemotherapy for people with non-small cell lung cancer that has spread or come back after previous treatment with an immunotherapy drug (PD-1/PD-L1 inhibitor) plus chemotherapy. The goal is to see if this combination can help shrink or control the cancer.
HefeiAges 18–75 - NCT07330544RecruitingPhase 2
Study of entinostat with anlotinib or fulvestrant for advanced breast cancer
This trial tests adding entinostat (a drug that may help hormone therapy work better) to anlotinib or fulvestrant for people with HR-positive, HER2-negative advanced breast cancer that has worsened after prior hormone therapy and a CDK4/6 inhibitor. It aims to find a new treatment option for those who cannot use chemotherapy yet.
Zhejiang, HangzhouAges 18 years+ - NCT07330648RecruitingPhase 2
Crisugabalin for generalized anxiety disorder
This study tests a new investigational drug called crisugabalin for people with generalized anxiety disorder (GAD) who have not found enough relief from at least two other anxiety medications. The trial aims to see if crisugabalin can safely reduce anxiety symptoms.
Hefei, AnhuiAges 18 years+ - NCT07330856RecruitingPhase 4
Testing treatments for recent dry or productive cough
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
Clermont-FerrandAges 18–65 - NCT07331883RecruitingPhase 2
Sintilimab and bevacizumab after surgery for ruptured liver cancer
This trial tests whether combining two immune-based drugs (sintilimab and a bevacizumab biosimilar) after surgery can prevent liver cancer from returning in people whose tumor had ruptured. It’s for patients who have had a complete surgical removal of a ruptured hepatocellular carcinoma and are now cancer-free on imaging.
Sanming, FujianAges 18–75 - NCT07331935Recruiting
Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia
This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.
AlexandriaAges 40 years+ - NCT07332273RecruitingPhase 3
Levothyroxine for weight loss in obesity
This trial tests whether adding levothyroxine (a thyroid hormone) to a low-calorie diet helps people with obesity lose more weight. It is for adults aged 25-60 with a BMI of 30-39.9 who have either mild underactive thyroid or normal thyroid but higher thyroid hormone levels in the normal range.
CadizAges 25–60 - NCT07334379RecruitingPhase 2
Tailored treatment for acute breathing problems
This trial tests whether using a blood test to measure inflammation (IL-6) can help doctors decide if you should get either dexamethasone or tocilizumab for COVID-19 or other acute breathing problems. The goal is to find the best treatment faster and reduce side effects.
Toronto, OntarioAges 18 years+ - NCT07334431RecruitingPhase 1/Phase 2
A trial of fruquintinib, trastuzumab, and chemo for HER2-positive stomach cancer
This study tests a combination of three drugs (fruquintinib, trastuzumab, and XELOX chemotherapy) as the first treatment for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The goal is to see if this combination is safe and effective for shrinking tumors.
Zhengzhou, HenanAges 18–75 - NCT07335081RecruitingPhase 2
ctDNA in HER2-positive early breast cancer before surgery
This trial is testing whether monitoring ctDNA (genetic material from the tumor in your blood) can help guide treatment for HER2-positive breast cancer before surgery. It is for people with early-stage (Stage II or III) disease who have not yet started treatment.
ShanghaiAges 18–70 - NCT07335367RecruitingPhase 2
PRP and Botox for hair loss: a study
This trial tests whether combining platelet-rich plasma (PRP) injections with botulinum toxin type A (Botox) can help regrow hair in people with male or female pattern baldness. It aims to see if this combination is safe and effective for treating androgenetic alopecia.
Guangzhou, GuangdongAges 18–60 - NCT07335627Recruiting
Clindamycin for strep knee or hip infections
This trial looks at whether the antibiotic clindamycin works well for treating joint replacement infections caused by strep bacteria. It may help people who had surgery for an infected artificial joint between 2013 and 2024.
StrasbourgAges 18 years+ - NCT07335900Recruiting
Studying heart healing after TAVI with FAPI-PET scan
This study uses a special type of PET scan (FAPI-PET) to see how the heart heals after a less invasive valve replacement procedure called TAVI. It aims to help doctors better understand the changes in heart tissue after treatment for aortic stenosis.
ShanghaiAges 18 years+ - NCT07336849Recruiting
Embolization for chronic shoulder pain not helped by other treatments
This trial tests a minimally invasive procedure called transcatheter arterial embolization using tiny particles (Nexsphere-F) to reduce chronic shoulder pain that has not improved with physical therapy, medications, or injections. It aims to see if this treatment can safely improve pain and shoulder movement.
SeoulAges 19–85 - NCT07337109Recruiting
Study on tooth sensitivity and quality of life
This study looks at how tooth sensitivity affects your daily life and what treatments people use. It is for people who have recently started having sensitive teeth and have tried products for it.
Las Vegas, NevadaAges 18 years+ - NCT07339631RecruitingPhase 1
Sodium Aescinate for Chronic Low Back Pain in Adults
This study tests an injectable medication called sodium aescinate (derived from horse chestnut) for people with chronic low back pain. It aims to see if it helps reduce pain and is safe to use.
Xi'an, ShaanxiAges 18–65 - NCT07339878Recruiting
Choosing the first treatment for advanced bladder cancer
This study looks at the different ways doctors choose the first treatment for patients whose urothelial cancer has spread. It aims to understand what factors influence that choice, which could help improve care for future patients.
StrasbourgAges 18 years+ - NCT07339904Recruiting
Bowel Function After Rectal Cancer Surgery
This study follows people with rectal cancer who have surgery to remove part of the rectum. It looks at how bowel function changes over time, and whether different treatments before surgery affect recovery.
Edegem, AntwerpAges 18 years+ - NCT07340463RecruitingPhase 2
Biologics vs standard therapy for lupus kidney disease
This trial tests two biologic drugs (belimumab or telitacicept) compared to a standard treatment (mycophenolate mofetil) for people with active lupus nephritis. The goal is to see if biologics work better at controlling kidney inflammation over 6 months.
Nanjing, JiangsuAges 14–65 - NCT07340554Recruiting
Brain imaging study for teens who use cannabis
This study looks at the brains of teenagers who use cannabis using an MRI scanner. It aims to understand how cannabis affects the developing brain, which might help improve treatment options.
Indianapolis, IndianaAges 14–17 - NCT07340606Recruiting
AI predictions for root canal success in painful molars
This study tests whether an AI tool can help predict if a simpler root canal treatment (pulpotomy) will work for back teeth with adult, painful pulp infections. If successful, it may help avoid more complex procedures.
CairoAges 20–45 - NCT07341074Recruiting
Early help for adults with mild traumatic brain injury
This study tests if offering early support soon after a mild head injury can help reduce ongoing symptoms. If you've recently had a mild traumatic brain injury (concussion) and are still having trouble, this program might help you recover better.
GroningenAges 18–70 - NCT07341438Recruiting
Physical activity for personality disorders
This trial is testing whether physical activity can help people with borderline or avoidant personality disorder. It is open to adults who are already getting treatment at two specific clinics in Denmark.
Gentofte Municipality, Capital RegionAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,573 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.